Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphatic vessel activation in cancer.

Melanie Cassella1, Mihaela Skobe

  • 1Derald H. Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, New York 10029, USA.

Annals of the New York Academy of Sciences
|January 25, 2003
PubMed
Summary

Tumor cells spread through the lymphatic system, and new findings show lymphatic vessel activation is crucial for cancer metastasis. Understanding tumor cell interaction with lymphatics is key for prognosis and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Recombinant Antibody Against Human DRP1 Serine 616 Phosphorylation Enables Detection of BRAF<sup>V600E</sup>-Associated Mitochondrial Division in Cancer.

Antibodies (Basel, Switzerland)·2026
Same author

A Recombinant Antibody Against Human DRP1 Serine 616 Phosphorylation Enables Detection of BRAF <sup>V600E</sup> -Associated Mitochondrial Division in Cancer.

bioRxiv : the preprint server for biology·2026
Same author

Lymphangiogenesis driven by VEGF-C reshapes tumor immune landscape and enables tumor eradication by viral immunotherapy.

bioRxiv : the preprint server for biology·2025
Same author

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.

Cancer cell·2022
Same author

High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer.

Nature communications·2021
Same author

3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine.

Nature communications·2021

Area of Science:

  • Oncology
  • Cancer Biology
  • Lymphatic System Research

Background:

  • Lymphatic system is a primary pathway for cancer metastasis.
  • Lymph node involvement is a critical prognostic indicator in most cancers.
  • Mechanisms of tumor cell interaction with lymphatic vessels remain poorly understood.

Purpose of the Study:

  • To investigate the role of lymphatic vessel activation in tumor dissemination.
  • To explore the mechanisms by which tumor cells enter lymphatic vessels.
  • To understand the significance of lymphangiogenesis in cancer metastasis.

Main Methods:

  • Analysis of tumor cell interaction with lymphatic vessels.
  • Investigation of lymphangiogenic factors like VEGF-C in tumors.
  • Assessment of lymphatic vessel density in relation to tumor metastasis.

Main Results:

  • VEGF-C production in tumors promotes lymphangiogenesis.
  • Increased lymphatic vessel density is associated with certain tumors.
  • Evidence suggests active lymphatic vessel involvement in tumor spread.

Conclusions:

  • The lymphatic system plays an active role in tumor metastasis, not just a passive one.
  • Lymphatic vessel activation is important for tumor cell dissemination.
  • Further research into tumor cell-lymphatic interactions is critical.

Related Experiment Videos